Effect of alternate day treatment with teneligliptin in type 2 diabetes mellitus patients.
- Conditions
- Health Condition 1: E119- Type 2 diabetes mellitus without complications
- Registration Number
- CTRI/2024/06/068564
- Lead Sponsor
- ONE
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
1) Patients with T2DM visiting Medicine / Endocrinology OPD/Ward who are taking metformin =1000 mg for a duration of 3 months or more.
2) Age:18- 59 years.
3) HbA1c 7-9 %
1) Type 1 Diabetes patients.
2) Patients taking metformin for less than 3 months duration.
3) Patients with known allergy to study drugs.
4) Pregnant and lactating women.
5)Patients with uncontrolled cardiovascular disorders.
6) Patients with severe life-threatening diseases.
7) Patients having renal dysfunction (serum creatinine 1.5 times more than the upper normal limit range).
8) Cases with hepatic dysfunction (SGOT and/ or SGPT levels 3-fold more than upper limit range).
9) Patients who have recent history of diabetic ketoacidosis.
10) Patients who are not willing / unable to give written informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method